Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Preemptive pardons to five family members, Dr. Fauci and the January 6 committee members, minutes before leaving office. This ...

Jardiance is the market leader in the SGLT2 ... but it became the first SGLT2 drug to be approved for CKD in diabetics last October, based on the results of the CREDENCE trial.

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

Although drug companies have sued over the negotiations ... They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia. The savings from the new list ...

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia. Drug company executives told investors during earnings calls that they did not expect the ...